Insight Molecular Diagnostics Inc. (NAS: IMDX) Stock Analysis & Fundamentals | ScreenerHero

Create free account

IMDXInsight Molecular Diagnostics Inc.

NAS · US · Healthcare · Diagnostics & Research · imdxinc.com

4.710USD-2.28%Mkt Cap: 152.09M $P/E: —1d ago

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap152.09M $

Enterprise Value130.51M $

Revenue (TTM)1.95M $

Gross Profit2.30M $

Net Income (TTM)-50.22M $

Revenue/Share0.0600 USD

Last Price4.710 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees55

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-6.04

PEG—

EV/EBITDA-4.00

EV/Revenue66.96

P/S78.03

P/B-14.23

EPS (TTM)-1.51

EPS (Forward)-0.78

52W Range

2.33039% of range8.510

52W High8.510 USD

52W Low2.330 USD

Profitability

Gross Margin56.67%

Oper. Margin-32275.00%

EBITDA Margin0.00%

Profit Margin-1238.52%

ROE159.62%

ROA-194.99%

Growth

Revenue Growth-98.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-22.18M $

CapEx (TTM)3.19M $

FCF Margin-803.47%

FCF Yield-10.30%

Net Debt-25.13M $

Net Debt/EBITDA0.77

Balance Sheet

Debt/Equity-0.11

Current Ratio2.54

Quick Ratio2.36

Book Value/Sh-0.3310 USD

Cash/Share0.8730 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJul 25, 2023

Analyst Consensus

Rating—

Target (Mean)8.333 USD

Upside (mean)+76.9%

Target Range4.000 USD – 12.00 USD

$4.000+76.9% to mean$12.00

# Analysts3

Ownership

Shares Out.32.29M

Float10.00M

Insiders21.28%

Institutions60.78%

Short Interest

Short Ratio3.9d

Short % Float6.36%

Short % Out.3.12%

Shares Short1.01M

Short (prev mo.)1.28M

Technical

SMA 505.548 (-15.1%)

SMA 2005.409 (-12.9%)

Beta1.76

S&P 52W Chg20.25%

Avg Vol (30d)258.87K

Avg Vol (10d)292.89K

Technical Indicators

RSI (14)41.5

MACD-0.2237

MACD Signal-0.1279

MACD Hist.-0.0957

BB Upper6.061 USD

BB Middle5.253 USD

BB Lower4.444 USD

BB Width30.77%

ATR (14)0.5327 USD

Vol Ratio (20d)0.67x